Christina Gentry, DVM, DACVM, shared a key dermatology takeaway from her co-presented CE session on concurrent disease.

InflaRx ( ($IFRX) ) has shared an announcement. On December 30, 2025, InflaRx reported detailed Phase 3 data analyses for vilobelimab in pyoderma ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

Gastroenterology specialists Dr Andy Li and Dr Jessica Gurung outline a rational approach to investigating recurrent ...

InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

InflaRx (IFRX) outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum, which was terminated earlier this ...

No Name Club were among the many groups to pay tribute to Edith Geraghty from Belmullet who passed away following an illness ...

This sexually transmitted infection is almost entirely preventable. Here's what experts say you really need to know to ...

Stripe is a payment service provider that accepts credit cards, digital wallets and many other payment methods. Many, or all, of the products featured on this page are from our advertising partners ...

The problem with PEDs use today is much more widespread and closer to home than many people believe, Pope warns. Both mass ...